Adjuvant Everolimus Fails to Stop Recurrence in Early High-Risk Breast Cancer
More than half of everolimus-treated patients permanently discontinued treatment
Source: medpagetoday.com
Stay updated with breaking news from Barts Center. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
More than half of everolimus-treated patients permanently discontinued treatment